Quality Assessment Creatinines in Plasma and Urine
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01575392 |
Recruitment Status :
Completed
First Posted : April 11, 2012
Last Update Posted : April 11, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Chronic Kidney Disease |
Apart from the 24-hour creatinine clearance, also formulas to estimate the glomerular filtration rate (GFR) are increasingly used to get an impression from renal function in recent years. Based on these renal function measurements, clinical decisions are made as well as drug dose adjustments. The use of reliable serum creatinine measurements is therefore important to get accurate renal function estimates. However, serum creatinine is one of the most variable routine laboratory tests.
The importance of calibration to a traceable reference measurement of serum creatinine has been stressed. However, this standardization does not correct for analytical non-specificity problems, which occurs in certain techniques to measure creatinine, leading to under- or overestimation of the true creatinine concentration.
The aim of this cross-sectional observational study is to examine the degree of variability between diverse methods to measure creatinine in plasma and urine in a heterogenous group of Caucasian people with and without renal function loss and the influence hereof on the 24-hour creatinine clearance and the Modification of Diet in Renal Disease study equation and the consequences for chronic kidney disease staging.
Study Type : | Observational |
Actual Enrollment : | 181 participants |
Time Perspective: | Cross-Sectional |
Official Title: | Quality Assessment of Creatinines in Plasma and Urine |
Study Start Date : | June 2010 |
Actual Primary Completion Date : | January 2011 |
Actual Study Completion Date : | January 2011 |

Group/Cohort |
---|
Patients coming for creatinine clearance
For this single group study, all patients presenting at the laboratory facility for a 24-hour creatinine clearance and patients in the dialysis population of the Isala Clinics who came for their periodical KT/V control, were informed about the study and asked to participate. Moreover, 20 'healthy' volunteers (including the investigators of this study and staff working at the clinical chemistry department of the Isala clinics) participated in this study.
|
- To investigate the bias and precision between routine laboratory techniques to measure creatinine in plasma, urine and dialysate when compared to the gold standard to measure creatinine. [ Time Frame: 6 months (plasma, urine and dialysate samples are collected only once during the running of the study) ]Creatinine concentrations of plasma, urine and/or dialysate samples will be measured using different techniques applied in daily clinical practice (jaffe, enzymatic and HPLC). For each participant creatinine will also be measured using the gold standard measure LC-MS. LCMS values will be used as reference method against which routine methods will be compared by means of absolute bias and precision per method group. Absolute bias is the mean difference between SCr values measured by individual laboratories and SCr target values; precision is defined as the SD of the absolute bias.
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- All patients >18 years presenting at the laboratory facility for a 24-hour creatinine clearance, or
- Persons >18 years, undergoing a renal replacing therapy by means of hemo-/peritoneal dialysis that had a KT/V appointment between May 2010 - January 2011
Exclusion Criteria:
- Patients <18 years

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01575392
Netherlands | |
Isala Clinics | |
Zwolle, Netherlands |
Principal Investigator: | I Drion, MD | Diabetes Centre, Isala Clinics, Zwolle, the Netherlands | |
Study Director: | Henk JG Bilo, Prof | Diabetes Centre, Isala Clinics, Zwolle, the Netherlands |
Responsible Party: | Nanne Kleefstra, ass. professor, Medical Research Foundation, The Netherlands |
ClinicalTrials.gov Identifier: | NCT01575392 |
Other Study ID Numbers: |
Krabbe_trial |
First Posted: | April 11, 2012 Key Record Dates |
Last Update Posted: | April 11, 2012 |
Last Verified: | April 2012 |
creatinine chronic kidney disease creatinine clearance estimated glomerular filtration rate |
Kidney Diseases Renal Insufficiency, Chronic Urologic Diseases Renal Insufficiency |